Adicet Bio's market cap is currently $82.40M. The company's EPS TTM is $-1.705; its P/E ratio is ―; Adicet Bio is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 24.99M	$ 9.73M	$ 17.90M	$ 995.00K
Gross Profit	$ -6.10M	$ 19.98M	$ 9.73M	$ 17.90M	$ 870.00K
Operating Income	$ -152.04M	$ -72.55M	$ -61.43M	$ -39.19M	$ -31.39M
EBITDA	$ -136.53M	$ -64.70M	$ -60.41M	$ -37.41M	$ -26.88M
Net Income	$ -142.66M	$ -67.03M	$ -62.00M	$ -36.68M	$ -28.14M
Balance Sheet
Cash & Short-Term Investments	$ 159.71M	$ 257.66M	$ 277.54M	$ 94.61M	$ 62.40M
Total Assets	$ 207.29M	$ 330.69M	$ 338.94M	$ 153.84M	$ 81.59M
Total Debt	$ 20.92M	$ 21.02M	$ 20.94M	$ 21.64M	$ 114.08M
Net Debt	$ -138.79M	$ -236.63M	$ -256.60M	$ -62.69M	$ 103.48M
Total Liabilities	$ 37.12M	$ 38.35M	$ 35.81M	$ 44.01M	$ 141.95M
Stockholders' Equity	$ 170.18M	$ -238.11M	$ -168.32M	$ -106.33M	$ -60.37M
Cash Flow
Free Cash Flow	$ -98.18M	$ -61.55M	$ -64.10M	$ -42.54M	$ -28.95M
Operating Cash Flow	$ -93.72M	$ -44.77M	$ -51.05M	$ -41.55M	$ -27.88M
Investing Cash Flow	$ -4.46M	$ -16.78M	$ -2.80M	$ 115.22M	$ -47.93M
Financing Cash Flow	$ 236.00K	$ 41.51M	$ 242.69M	$ 303.00K	$ 76.94M

Currency in USD

Adicet Bio Earnings and Revenue History

Income Statement >

Adicet Bio Debt to Assets

Balance Sheet >

Adicet Bio Cash Flow

Cash Flow >

Adicet Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing